CD45RChighCD4+ intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization.
暂无分享,去创建一个
H. Ishii | M. Yamazaki | T. Suzuki | Y. Iwao | S. Okamoto | N. Inoue | Y. Hosoda | N. Watanabe | M. Watanabe | T. Hibi | Y. Hamada | Y. Ueno | T. Yamada | M. Watanabe
[1] J. Mcghee,et al. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. , 1996, Journal of immunology.
[2] M. Neurath,et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. , 1996, Journal of immunology.
[3] M. Gershwin,et al. Analysis of function, specificity and T cell receptor expression of cloned mucosal T cell lines in Crohn's disease. , 1996, Journal of autoimmunity.
[4] Paul C. Rogers,et al. From Naive to Memory T Cells , 1996, Immunological reviews.
[5] H. Ishii,et al. Preferential activation of CD4+V beta 5.2/5.3+ intestinal intraepithelial lymphocytes in the inflamed lesions of Crohn's disease. , 1996, Clinical immunology and immunopathology.
[6] M. Neurath,et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice , 1995, The Journal of experimental medicine.
[7] R. P. Bucy,et al. Differences in the degree of depletion, rate of recovery, and the preferential elimination of naive CD4+ T cells by anti-CD4 monoclonal antibody (GK1.5) in young and aged mice. , 1995, Journal of immunology.
[8] H. Ishii,et al. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. , 1995, The Journal of clinical investigation.
[9] W. Brown,et al. Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease. , 1994, Gut.
[10] R. Coffman,et al. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.
[11] J. Watson,et al. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells , 1993, The Journal of experimental medicine.
[12] H. Waldmann,et al. Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies , 1993, Journal of Neuroimmunology.
[13] Tamaki Yamada,et al. A comparative analysis of two models of colitis in rats. , 1992, Gastroenterology.
[14] T. Bayless,et al. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. , 1992, Gastroenterology.
[15] D. Podolsky,et al. Inflammatory bowel disease (1) , 1991, The New England journal of medicine.
[16] M. Capobianchi,et al. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. , 1991, Gut.
[17] D. Mason,et al. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset [published erratum appears in J Exp Med 1991 Apr 1;173(4):1037] , 1990, The Journal of experimental medicine.
[18] T. Mosmann,et al. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.
[19] J. West,et al. A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines , 1989, European journal of immunology.
[20] J. Wallace,et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.
[21] S. James. Remission of Crohn's disease after human immunodeficiency virus infection. , 1988, Gastroenterology.
[22] M. Hurme,et al. Induction of TNP-specific cytotoxic T lymphocyte memory in vivo in the absence of T helper cell activity. , 1986, Journal of immunology.
[23] S. Sriram,et al. Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti-L3T4 antibodies. , 1986, Journal of immunology.
[24] M. Brandon,et al. MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen , 1983, The Journal of experimental medicine.
[25] S. V. van Deventer,et al. CD4 antibody treatment in Crohn's disease. , 1992, Scandinavian journal of gastroenterology. Supplement.
[26] J. Wallace,et al. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. , 1992, Gastroenterology.
[27] D. Mason,et al. Lineage relationships and functions of CD4+ T-cell subsets in the rat. , 1991, Research in immunology.